There are statistics that read like a slow emergency, and the latest school vaccination data is one of them. The share of kindergartners in the United States with exemptions from school vaccine requirements has risen to another record high. The numbers are not abstract. They track, year after year, toward a place public health experts spent decades trying to leave: a country where measles is once again a routine risk.
This is not a story about one vaccine or one state. It is a story about the slow erosion of a system that was, for a long time, one of public health’s quietest successes.
The numbers, plainly
The latest figures show roughly four percent of American kindergartners seeking exemptions from school vaccine requirements — up from under three percent a couple of years earlier. That is about 155,000 children in a single school year. In twenty-four states, the exemption rate now exceeds five percent.
Coverage for the core childhood vaccines — measles, mumps, rubella, diphtheria, tetanus, whooping cough, polio — is hovering just above ninety-two percent, and it has declined in more than half of all states compared with the year before. A few points of coverage sounds like a small change. It is not. Vaccines protect through herd immunity, and herd immunity has thresholds.
Why the number matters so much
For measles, the protection threshold is around ninety-five percent. Below that, the virus stops running into walls of immunity at every turn and starts finding enough susceptible people to spread from one classroom to the next. At ninety-two percent and falling, that margin is gone.
That is why the exemption rate is not a niche statistic. It is the leading indicator of where outbreaks will happen next. The communities where exemptions are highest are the communities where measles finds its footing first — a pattern that has been confirmed in outbreak after outbreak, in state after state.
The trap of success
Measles is not a mild disease, and the fact that it has come to sound like one is itself a sign of how completely the vaccine worked. Before vaccination, measles infected nearly every child, killed thousands a year, and could leave survivors with pneumonia, brain damage or permanent disability. The vaccine changed that so thoroughly that a generation grew up never seeing a case and concluded, understandably, that the disease was no longer worth worrying about.
That is the trap of success. When a disease disappears, the protection that made it disappear starts to look optional. And when enough people reach that conclusion at the same time, the disease comes back. The United States is currently fighting its worst measles resurgence in thirty-five years.
The reasons behind the rise
Understanding why exemptions are climbing requires honesty, because the reasons are not all the same, and they are not all easy to dismiss.
Some parents hold sincere religious beliefs about vaccination. That deserves respect, and the exemption system exists partly to accommodate it. But the fastest-growing category is not religious exemption. It is the catch-all personal-belief exemption — and it has been growing for reasons that have less to do with theology and more to do with misinformation, institutional distrust and a fragmented information environment.
There is also a structural factor that gets too little attention. Vaccine access is not equal. Coverage is lower in some rural and underserved communities not because parents are refusing, but because a clinic is far away, or a work schedule makes it impossible, or the information simply never reached them. Every exemption is not a refusal. Some of them are missed chances.
What the evidence actually says
When the data is examined closely, the picture is uncomfortable for both sides of the argument.
The vaccines in question are among the most studied medical products in history. Decades of trials, millions of doses, and no serious scientific evidence connecting them to the harms claimed by the most circulated misinformation. That is not an opinion; it is the conclusion of every reputable health body that has examined the question.
But it is also true that the public health system has not done a good job of making that case to ordinary parents, in ordinary language, before the misinformation reaches them. Public health has spent years fighting fires rather than building trust, and it shows. Parents who are uncertain are not stupid. They are often simply receiving better-marketed information from the wrong side.
The cost of the slow slide
The cost of this slide is not paid only by the families who skip vaccines. It is paid by everyone — especially by the children who cannot be vaccinated because they are too young, or are undergoing cancer treatment, or have conditions that make vaccination unsafe. They depend entirely on the immunity of the people around them. Every percentage point of coverage lost is a percentage point of protection removed from the most vulnerable people in the community.
There is also an economic cost that rarely gets counted. Outbreak responses are expensive: contact tracing, testing, hospitalizations, school closures, lost work. A single large measles outbreak can cost millions. The money spent on the consequences of an under-immunized population is money that was not spent on prevention, and the arithmetic does not favor delay.
What could turn it around
Turning this around will not be achieved by shaming parents, and it will not be achieved by a single policy. It will be a slower, less satisfying process.
It means meeting people where they are: answering the specific worry, not repeating the general message. It means making vaccination easier to reach — evening clinics, mobile services, school-based programs — for the families who are not refusing but falling through the cracks. It means strengthening the exemption rules where they have become broad enough to function as an easy opt-out, while keeping genuine religious accommodation. And it means accepting that rebuilding trust is measured in years, not in news cycles.
None of this is glamorous, and none of it can be done with a single announcement. But the alternative — watching the exemption rate climb one more decimal point every year, and the outbreaks return every few years with more force — is not a plan. It is just a drift.
The vaccine that ended measles in this country was introduced decades ago, and it worked so well that we allowed ourselves to forget why it existed. The current numbers are a reminder: protection is not a one-time achievement. It is something that has to be renewed, generation after generation — or quietly, bit by bit, it slips away.